Evogene Ltd. Cash Conversion Cycle 2011-2026 | EVGN

Annual Cash Conversion Cycle Evogene Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-32.5	32.6	-26.2	-30.8	-21.1	-56.2

All numbers in USD currency

Maximum	Minimum	Average
32.6	-56.2	-22.4

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Amphastar Pharmaceuticals AMPH	205	$ 21.87	2.15 %	$ 1.02 B	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	-400	$ 0.9	-	$ 6.62 M	China
ACADIA Pharmaceuticals ACAD	257	$ 22.28	1.46 %	$ 3.69 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aridis Pharmaceuticals ARDS	59	-	17.91 %	$ 11.1 M	USA
Aquestive Therapeutics AQST	-172	$ 4.1	0.37 %	$ 438 M	USA
Arcutis Biotherapeutics ARQT	158	$ 23.98	3.07 %	$ 3.05 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	119	$ 1.47	1.74 %	$ 391 M	Britain
AstraZeneca PLC AZN	-58	-	-	$ 96.9 B	Britain
BioDelivery Sciences International BDSI	340	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	-54.4	-	-	$ 546 M	USA
ContraFect Corporation CFRX	-1.83 K	-	-5.16 %	$ 5.39 M	USA
Cardiff Oncology CRDF	294	$ 1.72	-	$ 115 M	USA
BioXcel Therapeutics BTAI	-32.5 K	$ 1.1	3.76 %	$ 13.4 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
CASI Pharmaceuticals CASI	11.9	-	-	$ 35.4 M	USA